Clinical Trial Update: Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial) [NA]

View source ↗

Summary

A clinical trial evaluating AI-driven Medipixel fractional flow reserve versus invasive FFR-guided PCI is currently recruiting at Samsung Medical Center for cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Snippet

Sponsor: Samsung Medical Center | Conditions: Coronary Artery Disease, Chronic Coronary Syndrome | NA | Status: RECRUITING